The nation of Zimbabwe has turned down a substantial American healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive data.
This move became public after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official representative later stated that the US was requesting biological samples for scientific study and commercial gain but refused to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more talks to reach a deal suitable to both sides so the nation's critical HIV programme can proceed.
Wider Background
This rejection follows a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
Based on reports, Sixteen African countries have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our population should a future health crisis emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining structures previously established through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This system is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued discussions with our American counterparts on how subsequent co-operation might be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but recommended that talks must proceed given that much of the nation's HIV programmes depended on international support.
"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The situation underscores the continuing challenges between accepting much-needed international aid and protecting national sovereignty in an increasingly data-driven world.